Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $1.19 billion. The enterprise value is $1.07 billion.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 117.04 million shares outstanding. The number of shares has increased by 84.05% in one year.
| Current Share Class | 117.04M |
| Shares Outstanding | 117.04M |
| Shares Change (YoY) | +84.05% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 2.17% |
| Owned by Institutions (%) | 85.88% |
| Float | 84.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.29 |
| Forward PS | 4.79 |
| PB Ratio | 7.60 |
| P/TBV Ratio | 8.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 1.33.
| Current Ratio | 2.46 |
| Quick Ratio | 2.27 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.19 |
Financial Efficiency
Return on equity (ROE) is -192.31% and return on invested capital (ROIC) is -36.88%.
| Return on Equity (ROE) | -192.31% |
| Return on Assets (ROA) | -31.14% |
| Return on Capital (ROIC) | -36.88% |
| Revenue Per Employee | $468,608 |
| Profits Per Employee | -$660,591 |
| Employee Count | 296 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.04 |
Taxes
In the past 12 months, ARQT has paid $349,000 in taxes.
| Income Tax | 349,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +399.02% in the last 52 weeks. The beta is 1.19, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +399.02% |
| 50-Day Moving Average | 9.58 |
| 200-Day Moving Average | 9.47 |
| Relative Strength Index (RSI) | 56.50 |
| Average Volume (20 Days) | 2,278,994 |
Short Selling Information
The latest short interest is 27.76 million, so 23.71% of the outstanding shares have been sold short.
| Short Interest | 27.76M |
| Short Previous Month | 28.06M |
| Short % of Shares Out | 23.71% |
| Short % of Float | 33.03% |
| Short Ratio (days to cover) | 16.78 |
Income Statement
In the last 12 months, ARQT had revenue of $138.71 million and -$195.54 million in losses. Loss per share was -$1.73.
| Revenue | 138.71M |
| Gross Profit | 124.24M |
| Operating Income | -181.93M |
| Pretax Income | -214.05M |
| Net Income | -195.54M |
| EBITDA | -179.41M |
| EBIT | -181.93M |
| Loss Per Share | -$1.73 |
Full Income StatementBalance Sheet
The company has $330.56 million in cash and $208.18 million in debt, giving a net cash position of $122.38 million or $1.05 per share.
| Cash & Cash Equivalents | 330.56M |
| Total Debt | 208.18M |
| Net Cash | 122.38M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 156.64M |
| Book Value Per Share | 1.34 |
| Working Capital | 251.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$167.65 million and capital expenditures -$149,000, giving a free cash flow of -$167.80 million.
| Operating Cash Flow | -167.65M |
| Capital Expenditures | -149,000 |
| Free Cash Flow | -167.80M |
| FCF Per Share | -$1.43 |
Full Cash Flow StatementMargins
Gross margin is 89.57%, with operating and profit margins of -131.16% and -140.97%.
| Gross Margin | 89.57% |
| Operating Margin | -131.16% |
| Pretax Margin | -140.72% |
| Profit Margin | -140.97% |
| EBITDA Margin | -129.34% |
| EBIT Margin | -131.16% |
| FCF Margin | -186.72% |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.05% |
| Shareholder Yield | -84.05% |
| Earnings Yield | -16.41% |
| FCF Yield | -14.08% |
Analyst Forecast
The average price target for ARQT is $14.40, which is 41.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.40 |
| Price Target Difference | 41.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 66.27% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of -2.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.21 |
| Piotroski F-Score | 3 |